Cargando…

Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver

Protective mechanisms against drug-induced liver injury are actively being searched to identify new therapeutic targets. Among them, the anti-inflammatory N-acyl ethanolamide (NAE)-peroxisome proliferators activated receptor alpha (PPARα) system has gained much interest after the identification of i...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivera, Patricia, Pastor, Antoni, Arrabal, Sergio, Decara, Juan, Vargas, Antonio, Sánchez-Marín, Laura, Pavón, Francisco J., Serrano, Antonia, Bautista, Dolores, Boronat, Anna, de la Torre, Rafael, Baixeras, Elena, Lucena, M. Isabel, de Fonseca, Fernando R., Suárez, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635604/
https://www.ncbi.nlm.nih.gov/pubmed/29056914
http://dx.doi.org/10.3389/fphar.2017.00705
_version_ 1783270322306285568
author Rivera, Patricia
Pastor, Antoni
Arrabal, Sergio
Decara, Juan
Vargas, Antonio
Sánchez-Marín, Laura
Pavón, Francisco J.
Serrano, Antonia
Bautista, Dolores
Boronat, Anna
de la Torre, Rafael
Baixeras, Elena
Lucena, M. Isabel
de Fonseca, Fernando R.
Suárez, Juan
author_facet Rivera, Patricia
Pastor, Antoni
Arrabal, Sergio
Decara, Juan
Vargas, Antonio
Sánchez-Marín, Laura
Pavón, Francisco J.
Serrano, Antonia
Bautista, Dolores
Boronat, Anna
de la Torre, Rafael
Baixeras, Elena
Lucena, M. Isabel
de Fonseca, Fernando R.
Suárez, Juan
author_sort Rivera, Patricia
collection PubMed
description Protective mechanisms against drug-induced liver injury are actively being searched to identify new therapeutic targets. Among them, the anti-inflammatory N-acyl ethanolamide (NAE)-peroxisome proliferators activated receptor alpha (PPARα) system has gained much interest after the identification of its protective role in steatohepatitis and liver fibrosis. An overdose of paracetamol (APAP), a commonly used analgesic/antipyretic drug, causes hepatotoxicity, and it is being used as a liver model. In the present study, we have analyzed the impact of APAP on the liver NAE-PPARα system. A dose-response (0.5–5–10–20 mM) and time-course (2–6–24 h) study in human HepG2 cells showed a biphasic response, with a decreased PPARα expression after 6-h APAP incubation followed by a generalized increase of NAE-PPARα system-related components (PPARα, NAPE-PLD, and FAAH), including the NAEs oleoyl ethanolamide (OEA) and docosahexaenoyl ethanolamide, after a 24-h exposure to APAP. These results were partially confirmed in a time-course study of mice exposed to an acute dose of APAP (750 mg/kg). The gene expression levels of Pparα and Faah were decreased after 6 h of treatment and, after 24 h, the gene expression levels of Nape-pld and Faah, as well as the liver levels of OEA and palmitoyl ethanolamide, were increased. Repeated APAP administration (750 mg/kg/day) up to 4 days also decreased the expression levels of PPARα and FAAH, and increased the liver levels of NAEs. A resting period of 15 days completely restored these impairments. Liver immunohistochemistry in a well-characterized human case of APAP hepatotoxicity confirmed PPARα and FAAH decrements. Histopathological and hepatic damage (Cyp2e1, Caspase3, αSma, Tnfα, and Mcp1)-related alterations observed after repeated APAP administration were aggravated in the liver of Pparα-deficient mice. Our results demonstrate that the anti-inflammatory NAE-PPARα signaling system is implicated in liver toxicity after exposure to APAP overdose, and may contribute to its recovery through a long-term time-dependent response.
format Online
Article
Text
id pubmed-5635604
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-56356042017-10-20 Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver Rivera, Patricia Pastor, Antoni Arrabal, Sergio Decara, Juan Vargas, Antonio Sánchez-Marín, Laura Pavón, Francisco J. Serrano, Antonia Bautista, Dolores Boronat, Anna de la Torre, Rafael Baixeras, Elena Lucena, M. Isabel de Fonseca, Fernando R. Suárez, Juan Front Pharmacol Pharmacology Protective mechanisms against drug-induced liver injury are actively being searched to identify new therapeutic targets. Among them, the anti-inflammatory N-acyl ethanolamide (NAE)-peroxisome proliferators activated receptor alpha (PPARα) system has gained much interest after the identification of its protective role in steatohepatitis and liver fibrosis. An overdose of paracetamol (APAP), a commonly used analgesic/antipyretic drug, causes hepatotoxicity, and it is being used as a liver model. In the present study, we have analyzed the impact of APAP on the liver NAE-PPARα system. A dose-response (0.5–5–10–20 mM) and time-course (2–6–24 h) study in human HepG2 cells showed a biphasic response, with a decreased PPARα expression after 6-h APAP incubation followed by a generalized increase of NAE-PPARα system-related components (PPARα, NAPE-PLD, and FAAH), including the NAEs oleoyl ethanolamide (OEA) and docosahexaenoyl ethanolamide, after a 24-h exposure to APAP. These results were partially confirmed in a time-course study of mice exposed to an acute dose of APAP (750 mg/kg). The gene expression levels of Pparα and Faah were decreased after 6 h of treatment and, after 24 h, the gene expression levels of Nape-pld and Faah, as well as the liver levels of OEA and palmitoyl ethanolamide, were increased. Repeated APAP administration (750 mg/kg/day) up to 4 days also decreased the expression levels of PPARα and FAAH, and increased the liver levels of NAEs. A resting period of 15 days completely restored these impairments. Liver immunohistochemistry in a well-characterized human case of APAP hepatotoxicity confirmed PPARα and FAAH decrements. Histopathological and hepatic damage (Cyp2e1, Caspase3, αSma, Tnfα, and Mcp1)-related alterations observed after repeated APAP administration were aggravated in the liver of Pparα-deficient mice. Our results demonstrate that the anti-inflammatory NAE-PPARα signaling system is implicated in liver toxicity after exposure to APAP overdose, and may contribute to its recovery through a long-term time-dependent response. Frontiers Media S.A. 2017-10-06 /pmc/articles/PMC5635604/ /pubmed/29056914 http://dx.doi.org/10.3389/fphar.2017.00705 Text en Copyright © 2017 Rivera, Pastor, Arrabal, Decara, Vargas, Sánchez-Marín, Pavón, Serrano, Bautista, Boronat, de la Torre, Baixeras, Lucena, de Fonseca and Suárez. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Rivera, Patricia
Pastor, Antoni
Arrabal, Sergio
Decara, Juan
Vargas, Antonio
Sánchez-Marín, Laura
Pavón, Francisco J.
Serrano, Antonia
Bautista, Dolores
Boronat, Anna
de la Torre, Rafael
Baixeras, Elena
Lucena, M. Isabel
de Fonseca, Fernando R.
Suárez, Juan
Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver
title Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver
title_full Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver
title_fullStr Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver
title_full_unstemmed Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver
title_short Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver
title_sort acetaminophen-induced liver injury alters the acyl ethanolamine-based anti-inflammatory signaling system in liver
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635604/
https://www.ncbi.nlm.nih.gov/pubmed/29056914
http://dx.doi.org/10.3389/fphar.2017.00705
work_keys_str_mv AT riverapatricia acetaminopheninducedliverinjuryalterstheacylethanolaminebasedantiinflammatorysignalingsysteminliver
AT pastorantoni acetaminopheninducedliverinjuryalterstheacylethanolaminebasedantiinflammatorysignalingsysteminliver
AT arrabalsergio acetaminopheninducedliverinjuryalterstheacylethanolaminebasedantiinflammatorysignalingsysteminliver
AT decarajuan acetaminopheninducedliverinjuryalterstheacylethanolaminebasedantiinflammatorysignalingsysteminliver
AT vargasantonio acetaminopheninducedliverinjuryalterstheacylethanolaminebasedantiinflammatorysignalingsysteminliver
AT sanchezmarinlaura acetaminopheninducedliverinjuryalterstheacylethanolaminebasedantiinflammatorysignalingsysteminliver
AT pavonfranciscoj acetaminopheninducedliverinjuryalterstheacylethanolaminebasedantiinflammatorysignalingsysteminliver
AT serranoantonia acetaminopheninducedliverinjuryalterstheacylethanolaminebasedantiinflammatorysignalingsysteminliver
AT bautistadolores acetaminopheninducedliverinjuryalterstheacylethanolaminebasedantiinflammatorysignalingsysteminliver
AT boronatanna acetaminopheninducedliverinjuryalterstheacylethanolaminebasedantiinflammatorysignalingsysteminliver
AT delatorrerafael acetaminopheninducedliverinjuryalterstheacylethanolaminebasedantiinflammatorysignalingsysteminliver
AT baixeraselena acetaminopheninducedliverinjuryalterstheacylethanolaminebasedantiinflammatorysignalingsysteminliver
AT lucenamisabel acetaminopheninducedliverinjuryalterstheacylethanolaminebasedantiinflammatorysignalingsysteminliver
AT defonsecafernandor acetaminopheninducedliverinjuryalterstheacylethanolaminebasedantiinflammatorysignalingsysteminliver
AT suarezjuan acetaminopheninducedliverinjuryalterstheacylethanolaminebasedantiinflammatorysignalingsysteminliver